google-site-verification: googlec7193c3de77668c9.html

Weight-loss drug linked to rare eye condition

Novo Nordisk, the company that makes the drug, said patient safety was “a top priority” but the study had lots of limitations.

Trials show semaglutide can help people with obesity lose more than 10% of their body weight, if they also make changes to diet and lifestyle.

There has been huge hype around the drug after celebrities on social media starting posting about their sudden weight loss while taking it.

Despite it being available on prescription only to people with type 2 diabetes (Ozempic) and the most obese (Wegovy), online pharmacies are selling semaglutide injections with few checks on the weight or underlying health of the person buying them.

And as a result, health bosses say they are worried the drug is being misused as “a quick fix” for people trying to get “beach-body ready”.

All medicines carry potential side-effects.

Some of the most common for semaglutide include:

  • nausea

  • vomiting

  • diarrhoea

  • stomach pain

  • constipation

A change in vision is listed as one of the more serious potential side-effects, on both Ozempic and Wegovy’s safety information for patients.


Source link

Views: 0

See also  Researchers examine implementation of psychosocial support program for adolescents with cancer

Check Also

What are the plans for Liverpool Women's Hospital?

There are plans to move some maternity services to the Royal Liverpool – which could …

Single-cell platform tracks antibody drug delivery inside stubborn solid tumors

[ Credit: Pixabay/CC0 Public Domain A recent paper in Nature Biotechnology examines problems and solutions …

Up to half of life-threatening kidney disease cases remain undiagnosed, experts reveal

[ Credit: Unsplash/CC0 Public Domain Significant underdiagnosis of chronic kidney disease (CKD), now the ninth …

Leave a Reply

Available for Amazon Prime